论文发表
您当前的位置: 主页> 科学研究> 论文发表

论文发表

分享到:

1. Zong L, Wu A, Wang W, Deng J, Aikou S, Yamashita H, Maeda M, Abe M,Yu D,Jiang Z, Seto Y, Ji J. Feasibility of laparoscopic gastrectomy for elderly gastric cancer patients: meta-analysis of non-randomized controlled studies.Oncotarget. 2017 Mar 29.doi:10.18632/oncotarget.16691. 

2. Wang X, Wang QM, Meng Z, Yin Z, Luo X, Yu D. Gait disorder as a predictor of spatial learning and memory impairment in aged mice. PeerJ. 2017 Jan 5;5:e2854. doi: 10.7717/peerj.2854. eCollection 2017. 

3. Wang X, Chen A, Wu H, Ye M, Cheng H, Jiang X, Wang X, Zhang X, Wu D, Gu X,Shen F, Shan C, Yu D. Enriched environment improves post-stroke cognitive impairment in mice by potential regulation of acetylation homeostasis in cholinergic circuits. Brain Res.2016 Nov 1;1650:232-242. doi: 10.1016/j.brainres.2016.09.018. Epub 2016 Sep 13. 

4. Li YY, Gu J, Yu DN. [γ-Globin Inductive Therapy of β-thalassemia and Its Relationship with MicroRNA]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Apr;24(2):627-31. doi: 10.7534/j.issn.1009-2137.2016.02.060. Review. Chinese.

5. Yu L, Zhao Y, Gu X, Wang J, Pang L, Zhang Y, Li Y, Jia X, Wang X, Gu J, Yu D. Dual effect of LPS on murine myeloid leukemia cells: Pro-proliferation and anti-proliferation. Exp Cell Res. 2016 Jun 10;344(2):210-8. doi: 10.1016/j.yexcr.2016.03.006. Epub 2016 Mar 9. 

6. Zong L, Abe M, Ji J, Zhu WG, Yu D. Tracking the Correlation Between CpG Island Methylator Phenotype and Other Molecular Features and Clinicopathological Features in Human Colorectal Cancers: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol. 2016 Mar 10;7:e151. doi: 10.1038/ctg.2016.14. 

7. Li Y, Wang J, Dai X, Zhou Z, Liu J, Zhang Y, Li Y, Hou Y, Pang L, Wang X, WangC, Hao Z, Zhang Y, Jiang J, Cheng H, Yu D. miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer. Am J Transl Res. 2015 Dec 15;7(12):2775-85. eCollection 2015. 

8. Wang C, Wu X, Shen F, Li Y, Zhang Y, Yu D. Shlnc-EC6 regulates murine erythroid enucleation by Rac1-PIP5K pathway. Dev Growth Differ. 2015 Aug;57(6):466-73. doi: 10.1111/dgd.12225. Epub 2015 Jun 22.

9. Zhang J, Lu G, Kelly P, Zhang Z, Wei L, Yu D, Kayizha S, Wang C. First report of Rickettsia felis in China. BMC Infect Dis. 2014 Dec 16;14:682. doi: 10.1186/s12879-014-0682-1. 

10. Chung EY, Psathas JN, Yu D, Li Y, Weiss MJ, Thomas-Tikhonenko A. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis. J Clin Invest. 2012 Jun;122(6):2257-66. doi: 10.1172/JCI45851. Epub 2012 May 1.

11. Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML. Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells. PLoS One. 2012;7(1):e30656. doi: 10.1371/journal.pone.0030656. Epub 2012 Jan 23. 

12. Zhang XY, Pfeiffer HK, Mellert HS, Stanek TJ, Sussman RT, Kumari A, Yu D, Rigoutsos I, Thomas-Tikhonenko A, Seidel HE, Chodosh LA, Packham G, Baserga R, McMahon SB. Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC. Mol Cell Biol. 2011 Dec;31(24):5037-45. doi: 10.1128/MCB.06297-11. Epub 2011 Oct 10. 

13. Yu D, dos Santos CO, Zhao G, Jiang J, Amigo JD, Khandros E, Dore LC, Yao Y, D'Souza J, Zhang Z, Ghaffari S, Choi J, Friend S, Tong W, Orange JS, Paw BH, Weiss MJ. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 2010 Aug 1;24(15):1620-33. doi: 10.1101/gad.1942110.

14. Zhao G, Yu D, Weiss MJ. MicroRNAs in erythropoiesis. Curr Opin Hematol. 2010 May;17(3):155-62. doi: 10.1097/MOH.0b013e328337ba6c. Review. 

15. Yu M, Riva L, Xie H, Schindler Y, Moran TB, Cheng Y, Yu D, Hardison R, Weiss MJ, Orkin SH, Bernstein BE, Fraenkel E, Cantor AB. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell. 2009 Nov 25;36(4):682-95. doi: 10.1016/j.molcel.2009.11.002. 

16. Cheng Y, Wu W, Kumar SA, Yu D, Deng W, Tripic T, King DC, Chen KB, Zhang Y, Drautz D, Giardine B, Schuster SC, Miller W, Chiaromonte F, Zhang Y, Blobel GA, Weiss MJ, Hardison RC. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res. 2009 Dec;19(12):2172-84. doi: 10.1101/gr.098921.109. Epub 2009 Nov 3.

17. Chung EY, Dews M, Cozma D, Yu D, Wentzel EA, Chang TC, Schelter JM, Cleary MA, Mendell JT, Thomas-Tikhonenko A. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther. 2008 Nov;7(11):1758-64. Epub2008 Nov 4. 

18. Dore LC, Amigo JD, Dos Santos CO, Zhang Z, Gai X, Tobias JW, Yu D, Klein AM,Dorman C, Wu W, Hardison RC, Paw BH, Weiss MJ. A GATA-1-regulated microRNA locus essential for erythropoiesis. Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3333-8. doi:10.1073/pnas.0712312105. Epub 2008 Feb 26. PubMed PMID: 18303114; 

19. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2008 Jan;40(1):43-50. Epub 2007 Dec 9.

20. Kumar KG, Liu J, Li Y, Yu D, Thomas-Tikhonenko A, Herlyn M, Fuchs SY. Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells. Cancer Biol Ther. 2007 Sep;6(9):1437-41. Epub 2007 Jun 13. 

21. Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH,Paterson J, Erikson J, Marafioti T, Monroe JG, Atchison ML, Thomas-Tikhonenko A. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling. J Clin Invest. 2007 Sep;117(9):2602-10. 

22. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007 Feb;117(2):326-36. Epub 2007 Jan 18. 

23. Hodawadekar S, Yu D, Cozma D, Freedman B, Sunyer O, Atchison ML, Thomas-Tikhonenko A. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages. Exp Cell Res. 2007 Jan 15;313(2):331-40. Epub 2006 Oct 25. 

24. Hodawadekar S, Wei F, Yu D, Thomas-Tikhonenko A, Atchison ML. Epigenetic histone modifications do not control Igkappa locus contraction and intranuclear localization in cells with dual B cell-macrophage potential. J Immunol. 2006 Nov 1;177(9):6165-71.

25. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006 Sep;38(9):1060-5. Epub 2006 Jul 30. 

26. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, Dang CV.Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol. 2006 Mar;26(6):2373-86. 

27. Yu D, Cozma D, Park A, Thomas-Tikhonenko A. Functional validation of genes implicated in lymphomagenesis: an in vivo selection assay using a Myc-induced B-cell tumor. Ann N Y Acad Sci. 2005 Nov;1059:145-59. 

28. Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A, McMahon SB. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13968-73. Epub 2005 Sep 19. 

29. Yu D, Dews M, Park A, Tobias JW, Thomas-Tikhonenko A. Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies. Cancer Res. 2005 Jun 15;65(12):5454-61.

30. Tang W, Li Y, Yu D, Thomas-Tikhonenko A, Spiegelman VS, Fuchs SY. Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells. Cancer Res. 2005 Mar 1;65(5):1904-8.

31. Ricci MS, Jin Z, Dews M, Yu D, Thomas-Tikhonenko A, Dicker DT, El-Deiry WS. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol Cell Biol. 2004 Oct;24(19):8541-55. 

32. Johnson K, Pflugh DL, Yu D, Hesslein DG, Lin KI, Bothwell AL, Thomas-Tikhonenko A, Schatz DG, Calame K. B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5. Nat Immunol. 2004 Aug;5(8):853-61. Epub 2004 Jul 18. 

33. Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W, Aronow B, Kaya G, Saurat JH, French LE. Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res. 2004 May 1;64(9):3126-36. 

34. Rankin EB, Yu D, Jiang J, Shen H, Pearce EJ, Goldschmidt MH, Levy DE, Golovkina TV, Hunter CA, Thomas-Tikhonenko A. An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth. Cancer Biol Ther. 2003 Nov-Dec;2(6):687-93. 

35. Yu D, Allman D, Goldschmidt MH, Atchison ML, Monroe JG, Thomas-Tikhonenko A.Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood. 2003 Mar 1;101(5):1950-5. Epub 2002 Oct 24.

36. Yu D, Thomas-Tikhonenko A. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Oncogene. 2002 Mar 14;21(12):1922-7. 


地址:扬州市淮海路11号 邮编:225001 电话:0514-87978804 传真:0514-87341733 E-mail:yixy@yzu.edu.cn
Copyright @ 2017 版权所有:扬州大学 Yangzhou University
技术支持: 扬州市展望计算机网络有限公司  ICP备案编号: 苏ICP备89059003号-1
66利来官